Cargando…
PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer
In the current retrospective cohort study, the expression of the Proteasome 26S non-ATPase Subunit 9 (PSMD9) was investigated in 102 patients with cervical cancer. The rat homologue of PSMD9, Bridge-1, was identified as a binding protein of the transcription factors PDX-1 and E-12 via its PDZ-domain...
Autores principales: | Köster, Frank, Sauer, Lisa, Hoellen, Friederike, Ribbat-Idel, Julika, Bräutigam, Karen, Rody, Achim, Banz-Jansen, Constanze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285846/ https://www.ncbi.nlm.nih.gov/pubmed/32565983 http://dx.doi.org/10.3892/ol.2020.11622 |
Ejemplares similares
-
Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion
por: Hoellen, Friederike, et al.
Publicado: (2016) -
PSMD9 expression predicts radiotherapy response in breast cancer
por: Langlands, Fiona E, et al.
Publicado: (2014) -
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022) -
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020) -
Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma
por: Hakim, Samer George, et al.
Publicado: (2023)